Cargando…

Corrigendum to: Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754568/
https://www.ncbi.nlm.nih.gov/pubmed/31504419
http://dx.doi.org/10.1093/eurheartj/ehz630
_version_ 1783453095541342208
collection PubMed
description
format Online
Article
Text
id pubmed-6754568
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-67545682019-09-25 Corrigendum to: Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial Eur Heart J Corrigenda Oxford University Press 2019-09-21 2019-08-29 /pmc/articles/PMC6754568/ /pubmed/31504419 http://dx.doi.org/10.1093/eurheartj/ehz630 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Corrigenda
Corrigendum to: Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial
title Corrigendum to: Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial
title_full Corrigendum to: Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial
title_fullStr Corrigendum to: Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial
title_full_unstemmed Corrigendum to: Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial
title_short Corrigendum to: Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial
title_sort corrigendum to: uninterrupted edoxaban vs. vitamin k antagonists for ablation of atrial fibrillation: the eliminate-af trial
topic Corrigenda
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754568/
https://www.ncbi.nlm.nih.gov/pubmed/31504419
http://dx.doi.org/10.1093/eurheartj/ehz630